Healthcare >> CEO Interviews >> February 16, 2015

Interview with the President & CEO: Osprey Medical Inc. (ASX:OSP)

Mike McCormick
Mike McCormick was appointed President & CEO of Osprey Medical Inc. in March 2010. Mr. McCormick has more than 25 years of experience in the medical device industry, and president-level experience with public and private medical device companies. From 2003 to 2008, Mr. McCormick was President and CEO of Anulex Technologies, Inc., a private company focused on developing proprietary technologies to support the healing of spinal soft tissues. Prior to this, he was President of Centerpulse Spine-Tech, a publicly traded full-line supplier of innovative spinal technologies with over 400 employees and $125 million in annual revenues. Mr. McCormick was involved in the successful sale of Centerpulse Inc. to Zimmer in 2003 for $3.2 billion. Early in his career, Mr. McCormick worked at Boston Scientific Scimed for 10 years and Baxter Health Care, where he served in a variety of sales and sales management roles. He received his Bachelor of Business Administration, Business Management from the University of Texas at Austin. Mr. McCormick is Chairman of the board at OrthoCor Medical, Inc., a commercial-stage private company based in Minnesota, and he is a member of the board of directors of Formae, Inc. a private company in the orthopaedics space. Profile
TWST: Could provide a brief overview of the company?

Mr. McCormick: Osprey Medical is focused on technologies that reduce patients' risk when undergoing a cardiovascular procedure that